These findings, suggesting that these CFTR modulators might have additional immunomodulatory benefits to prevent or treat Aspergillus-induced inflammation [112], are particularly relevant considering that A. fumigatus colonization is frequent in CF and worsens pulmonary exacerbations [113]. The gene discussed is CFTR; the disease is cystic fibrosis.